CanSaRCC Membership
There are 2 different types of CanSaRCC membership: general and contributing.
What is a General Member?
General Members are physicians and scientists who would like to declare their status as providers in the care of patients with sarcoma.
What is a Contributing Member?
Contributing Members are physicians and scientists who would like to contribute clinical data and/or tissue to our national database.
Only Contributing Members will then have access to data/tissue submitted for specific projects that have been approved.
| |
General Member |
Contributing Member |
| Access to internal webpages for members |
|
|
| View all Project Requests and Status |
|
|
| View Membership Directory |
|
|
| Free use of the CanSaRCC Infrastructure |
|
|
| Ability to access your Site Data and Enter Data |
|
|
| Ability to Submit Data Requests |
|
|
| Ability to Lead a National Project |
|
|
Become a Contributing Member & Submit Project and Data Request
In order to become a contributing member that will permit you to submit and access data, you must complete the steps below.
Step1: Register to CanSaRCC website and check the box "contributing member"
https://www.cansarcc.ca/register
Step2: We will approve your request within 24hr
Now you are a contributing member
Step 3: Ensure your site has valid CanSaRCC signed Consortium Agreement &
Valid CanSaRCC master REB
Step 4: Work on your local subREb - Only if you are the lead site/PI of a project.
Step 5: Ensure you have internal or external UHN tID and Access to the CanSaRCC RedCap Database
https://www.cansarcc.ca/redcap
Step 5: log into
https://www.cansarcc.ca/ and submit a project request, including sign Exhibit B, Data Collection Sheet and protocol - https://www.cansarcc.ca/submit-project-request
Step 6: The CanSaRCC Core Team will meet with you and help design your project to ensure you obtain the most accurate data and maximize your sample size.
Step 7: Steering Committee Review, Feedback & Approval within 3 weeks.
You are now ready to begin your study and contribute to improving outcomes for patients with sarcoma.